[Adjuvant treatment for colon carcinoma. Results and perspectives].
Wein
A
A
Medizinische Klinik I, Friedrich-Alexander-Universität Erlangen.
Riedel
C
C
Lehnert
T
T
Wakker
R
R
Reingruber
B
B
Teichmann
W
W
Kohnen
R
R
Herfarth
C
C
Hohenberger
W
W
Hahn
E G
EG
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000931:Antidotes / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D005472:Fluorouracil / Q000008:administration & dosage; D005858:Germany; D006801:Humans; D007167:Immunotherapy; D002955:Leucovorin / Q000008:administration & dosage; D007978:Levamisole / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012955:Societies, Medical
D000276:Adjuvants, Immunologic; D000931:Antidotes; D000964:Antimetabolites, Antineoplastic; D007978:Levamisole; D002955:Leucovorin; D005472:Fluorouracil
Adjuvante Behandlung beim Kolonkarzinom. Resultate und Perspektiven.